Vorinostat: HDAC Inhibitor for Cancer Biology & Apoptosis...
2025-10-21
Vorinostat (SAHA) is transforming cancer biology research by enabling precise interrogation of epigenetic modulation and intrinsic apoptotic pathways. This guide details experimental workflows, advanced use-cases, and troubleshooting strategies that help researchers maximize the value of this potent histone deacetylase inhibitor for cancer research.